Literature DB >> 18199772

Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults.

Nicola Maggio1, Efrat Shavit, Joab Chapman, Menahem Segal.   

Abstract

The effects of thrombin, a blood coagulation serine protease, were studied in rat hippocampal slices, in an attempt to comprehend its devastating effects when released into the brain after stroke and head trauma. Thrombin acting through its receptor, protease-activated receptor 1 (PAR1), produced a long-lasting enhancement of the reactivity of CA1 neurons to afferent stimulation, an effect that saturated the ability of the tissue to undergo tetanus-induced long-term potentiation. This effect was mediated by activation of a PAR1 receptor, because it was shared by a PAR1 agonist, and was blocked by its selective antagonist. An independent effect of thrombin involved the lowering of the threshold for generating epileptic seizures in CA3 region of the hippocampus. Thus, the experiments in a slice mimicked epileptic and cognitive dysfunction induced by thrombin in the brain, and suggest that these effects are mediated by activation of the PAR1 receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199772      PMCID: PMC6670357          DOI: 10.1523/JNEUROSCI.3665-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Thrombin and the Protease-Activated Receptor-1 in Organophosphate-Induced Status Epilepticus.

Authors:  Valery Golderman; Efrat Shavit-Stein; Orna Gera; Joab Chapman; Arik Eisenkraft; Nicola Maggio
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

Review 2.  Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy.

Authors:  Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Glia       Date:  2012-02-29       Impact factor: 7.452

3.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

Review 4.  Modulation of Synaptic Plasticity by Exercise Training as a Basis for Ischemic Stroke Rehabilitation.

Authors:  Jingjing Nie; Xiaosu Yang
Journal:  Cell Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.046

5.  Thrombin: is it on a par with seizures and epilepsy?

Authors:  Kevin M Kelly
Journal:  Epilepsy Curr       Date:  2008 Jul-Aug       Impact factor: 7.500

6.  Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion.

Authors:  Drew L Sellers; Tae Hee Kim; Christopher W Mount; Suzie H Pun; Philip J Horner
Journal:  Biomaterials       Date:  2014-07-23       Impact factor: 12.479

7.  PAR1-activated astrocytes in the nucleus of the solitary tract stimulate adjacent neurons via NMDA receptors.

Authors:  Katie M Vance; Richard C Rogers; Gerlinda E Hermann
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

8.  Reversal of trauma-induced amnesia in mice by a thrombin receptor antagonist.

Authors:  Zeev Itzekson; Nicola Maggio; Anat Milman; Efrat Shavit; Chaim G Pick; Joab Chapman
Journal:  J Mol Neurosci       Date:  2013-12-19       Impact factor: 3.444

9.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

10.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.